Marion T van Mackelenbergh (Marion van Mackelenbergh)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Early Breast Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Paul Jank, Thomas Karn, Marion T van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, Knut Engels, Christine Solbach, Kurt Diebold, Frederic Marmé, Volkmar Mueller, Andreas Schneeweiß, Hans-Peter Sinn, Tanja Fehm, Christian Schem, Elmar Stickeler, Peter Andreas Fasching, Jan Budczies, Bärbel Felder, Valentina Nekljudova, Johannes Holtschmidt, Michael Untch, Carsten Denkert, Sibylle Loibl
An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in breast cancer patients from four prospective clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter Andreas Fasching, Christopher W Szeto, Carsten Denkert, Stephen Charles Benz, Karsten E Weber, Patricia Spilman, Jan Budczies, Andreas Schneeweiß, Elmar Stickeler, Sabine Schmatloch, Christian Jackisch, Thomas Karn, Hans-Peter Sinn, Mathias Warm, Marion T van Mackelenbergh, Shahrooz Rabizadeh, Christian Schem, Ernst Heinmöller, Volkmar Mueller, Frederic Marmé, Patrick Soon-Shiong, Valentina Nekljudova, Michael Untch, Sibylle Loibl
Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Terence M Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E Weber, Peter Andreas Fasching, Carsten Denkert, Jenny Furlanetto, Ernst Heinmöller, Sabine Schmatloch, Thomas Karn, Christopher W Szeto, Marion T van Mackelenbergh, Valentina Nekljudova, Elmar Stickeler, Patrick Soon-Shiong, Christian Schem, Thomas Mairinger, Volkmar Mueller, Frederic Marmé, Michael Untch, Sibylle Loibl
Caveolin gene expression predicts clinical outcomes for early-stage HER2-negative breast cancer treated with paclitaxel-based chemotherapy in the GeparSepto trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jens Huober, Marion T van Mackelenbergh, Andreas Schneeweiss, Fenja Seither, Jens-Uwe Blohmer, Carsten Denkert, Hans Tesch, Claus Hanusch, Christoph Salat, Kerstin Rhiem, Christine Solbach, Peter Andreas Fasching, Christian Jackisch, Mattea Reinisch, Bianca Lederer, Keyur Mehta, Theresa Link, Valentina Nekljudova, Sibylle Loibl, Michael Untch
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy. NPJ breast cancer 9 (1) (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
André Pfob, Chris Chris Sidey-Gibbons, Geraldine Rauch, Bettina Thomas, Benedikt Schaefgen, Sherko Kuemmel, Toralf Reimer, Markus Hahn, Marc Thill, Jens-Uwe Blohmer, John Hackmann, Wolfram Malter, Inga Bekes, Kay Friedrichs, Sebastian Wojcinski, Sylvie Joos, Stefan Paepke, Tom Degenhardt, Joachim Rom, Achim Rody, Marion T van Mackelenbergh, Maggie Banys-Paluchowski, Regina Große, Mattea Reinisch, Maria Karsten, Michael Golatta, Joerg Heil
Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)